Mark N. Diker is Director at CANTEL MEDICAL CORP (CMN). They have made 9 open-market trades across 2 companies since 2008, most recently 2021-06-02.
CIK 0001415034
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $174K since 2008, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMD | BUY | 2020-01-17 | 2020-01-22 | $62.43 | $125K | -5.3% | +2.6% | -60.1% |
| CMD | SELL | 2018-01-17 | 2018-01-19 | $111.77 | $559K | -2.0% | -0.7% | +1.8% |
| CMD | SELL | 2017-10-03 | 2017-10-05 | $98.90 | $692K | -1.5% | +0.1% | +5.5% |
| CMN | SELL | 2016-06-10 | 2016-06-14 | $73.30 | $513K | -4.6% | -4.8% | +7.4% |
| CMN | SELL | 2015-09-30 | 2015-10-02 | $56.64 | $566K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2015-04-08 | 2015-04-09 | $49.35 | $592K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2013-09-30 | 2013-10-02 | $31.46 | $787K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2012-06-19 | 2012-06-21 | $27.30 | $259K | -7.1% | -3.4% | -3.4% |
| CMN | BUY | 2008-03-07 | 2008-03-07 | $9.85 | $49K | -7.1% | -3.4% | -3.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.